The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

"Experimental drug guadecitabine found safe in patients with colorectal cancer":

Comments

  • JanJan63
    JanJan63 CSN Member Posts: 2,477 Member
    Interesting. So it's for

    Interesting. So it's for people who's cancer cells have developed a resistance to treatment with the drug mentioned. I wish I'd gotten into cancer research when I was younger. I'd feel like I was doing something to help instead of sitting around hoping someone will come up with something.

    Jan

  • coloCan
    coloCan CSN Member Posts: 1,944 Member
    JanJan63 said:

    Interesting. So it's for

    Interesting. So it's for people who's cancer cells have developed a resistance to treatment with the drug mentioned. I wish I'd gotten into cancer research when I was younger. I'd feel like I was doing something to help instead of sitting around hoping someone will come up with something.

    Jan

    The current AACR meeting will probably have reports of more

    trials, such as BGB-283 (http://ecancer.org/news/9088

  • mukamom
    mukamom CSN Member Posts: 402
    coloCan said:

    The current AACR meeting will probably have reports of more

    trials, such as BGB-283 (http://ecancer.org/news/9088

    Interesting. Always looking for

    new trials. Too bad the trials are only in CA and MD...